Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death

F H Messerli1, T Grodzicki

  • 1Department of Internal Medicine, Ochsner Clinic, New Orleans, Louisiana 70121.

European Heart Journal
|September 1, 1992
PubMed

Insights

Left ventricular hypertrophy (LVH) increases cardiovascular risk and sudden death. Reducing LVH with antihypertensive therapy can decrease ventricular arrhythmias and potentially lower this risk.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Electrophysiology

Background:

  • Left ventricular hypertrophy (LVH) is a common consequence of arterial hypertension.
  • LVH independently elevates risks of sudden death, cardiovascular morbidity, and mortality.
  • Ventricular arrhythmias are frequently observed in patients with LVH and linked to sudden cardiac death.

Purpose of the Study:

  • To investigate the impact of reducing LVH on ventricular arrhythmias.
  • To explore the potential of antihypertensive therapy in mitigating LVH-associated cardiovascular risks.

Main Methods:

  • Review of electrophysiological studies and clinical findings.
  • Analysis of antihypertensive treatments and their efficacy in reducing LVH.
  • Assessment of the relationship between LVH reduction and ventricular ectopy.

Main Results:

  • Specific antihypertensive therapies can reduce LVH, though drug potency varies.
  • A decrease in LVH has been correlated with a reduction in ventricular ectopy.
  • Preliminary data suggest that mitigating LVH and arrhythmias may lower cardiovascular risk.

Conclusions:

  • LVH is a significant cardiovascular risk factor associated with hypertension.
  • Therapeutic reduction of LVH may decrease ventricular arrhythmias.
  • Further research is warranted to confirm if LVH and arrhythmia reduction lowers overall cardiovascular risk.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...